# Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches

> **NCT04410263** · — · UNKNOWN · sponsor: **University of Zurich** · enrollment: 300 (estimated)

## Conditions studied

- Corona Virus Infection
- ARDS
- Coinfection

## Interventions

- **DIAGNOSTIC_TEST:** Sampling (EDTA blood, pharyngeal and nose swabs, bronchoalveolar lavage ,urine)

## Key facts

- **NCT ID:** NCT04410263
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-09
- **Primary completion:** 2023-12-30
- **Final completion:** 2023-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2020-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04410263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04410263, "Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04410263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*